Drug Action
Dexamethasone has very high glucocorticoid activity and insignificant mineralocorticoid activity.
PDF page 1238
Drug reference
Dexamethasone has very high glucocorticoid activity and insignificant mineralocorticoid activity.
PDF page 1238
Local inflammation of joints ▶BY INTRA-ARTICULAR INJECTION ▶Adult: 0.3–3.3 mg, where appropriate, dose may be repeated at intervals of 3–21 days according to response, dose given according to size—consult product literature Local inflammation of soft tissues ▶BY LOCAL INFILTRATION ▶Adult: 1.7–5 mg, dose given according to size—consult product literature, where appropriate may be repeated at intervals of 3–21 days, use the 3.3 mg/mL injection preparation for this dose
PDF page 1238
Dexamethasone 3.8 mg/mL Injection has replaced dexamethasone 4 mg/mL Injection. All dosage recommendations for intravenous, intramuscular, intrarticular use or local infiltration; are given in units of dexamethasone base.
PDF page 1238
→Appendix 1: corticosteroids
PDF page 1238
Dexamethasone readily crosses the placenta.
PDF page 1238
There can be variation in the licensing of different medicines containing the same drug. Solution for injection CAUTIONARY AND ADVISORY LABELS 10 ▶Dexamethasone (Non-proprietary) Dexamethasone (as Dexamethasone sodium phosphate) 3.3 mg per 1 ml Dexamethasone (base) 6.6mg/2ml solution for injection ampoules | 10 ampoule P £22.00 DT = £22.00 Dexamethasone (base) 6.6mg/2ml solution for injection vials | 5 vial P £24.00 DT = £24.00 Dexamethasone (base) 3.3mg/1ml solution for injection ampoules | 5 ampoule P £12.00 | 10 ampoule P £15.00–£23.66 DT = £23.66 Dexamethasone (as Dexamethasone sodium phosphate) 3.8 mg per 1 ml Dexamethasone (base) 3.8mg/1ml solution for injection vials | 10 vial P £19.99 DT = £20.00 (Hospital only) | 10 vial P £19.99–£20.00 DT = £20.00 eiiii F 709
PDF page 1238
0.3–3.3 mg, where appropriate, dose may be
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1238
1.7–5 mg, dose given according to size—consult
First-line fragment. Read the complete Indications and Dose section above.
PDF page 1238